share_log

Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results

SEC ·  Nov 4, 2022 04:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more